Results 1 to 1 of 1
01-10-2013, 01:00 PM #1
Mobius Therapeutics, LLC Issues a Voluntary Recall of Mitosol® (mitomycin for solutio
On 10 January 2013, Mobius Therapeutics, LLC, St. Louis, MO, announced today that it is conducting a voluntary recall of 2 lots of Mitosol® (mitomycin for solution), 0.2 mg/vial, Kit for Ophthalmic Use. The company is taking this voluntary action due to the fact that we cannot exclude the possibility that the affected lots may be non-sterile.